Comments on: Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPenĀ® with Accelerated Speed to Therapeutic Threshold https://thegbm.com/nasus-pharma-announces-positive-top-line-data-from-phase-2-clinical-study-of-ns002-achieves-significantly-superior-and-faster-epinephrine-delivery-compared-to-epipen-with-accelerated-speed-to/ Business news, opinion, reviews, interviews Mon, 16 Mar 2026 11:30:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4